Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.

Gadoquatrane is a new MRI contrast agent that uses a much lower gadolinium dose. It may help reduce lifetime gadolinium exposure. Studies show similar safety and drug profiles in children and adults.

Gadolinium key in improving MRI scan quality Rare earths market shifting amid export controls Australia expands access to diagnostic imaging Gadolinium, a rare earth element, is gaining attention as ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

Scientists at Oregon State University (OSU) have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic ...

Washington Commanders quarterback Jayden Daniels will undergo MRI testing to determine the severity of a dislocated elbow injury to his left, non-throwing arm that he suffered Sunday during a 38-14 ...

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI. HealthDay News — Biparametric magnetic resonance imaging (MRI), which omits the ...

Biparametric MRI, which omits dynamic contrast-enhanced sequences, similarly detected clinically significant prostate cancer to multiparametric MRI. Biparametric MRI was also noninferior to ...

A twist on magnetic resonance imaging that does not require gadolinium contrast appears to be as effective as standard imaging at detecting prostate cancers, according to a new study in JAMA. Experts ...

Disclaimer: Important, this article is for general information only and is not medical advice. Please speak to your clinician about your personal risks and benefits. If you experience symptoms after ...